Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Pyridine 3 Carboxyamide Derivative”
Abstract: Provided is a novel JAK3 inhibitor useful as a preventive and/or therapeutic agent for organ transplant rejection, graft versus host disease (GvHD), rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjogren’s syndrome, Behcet""s disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn""s disease, asthma, allergic conjunctivitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia, etc. A pyridine-3-carboxyamide derivative represented by general formula (1) or a salt thereof or a solvate thereof or a salt or a solvate thereof.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
24 June 2011
Publication Number
33/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
ipo@knspartners.com
Parent Application
Applicants
KOWA COMPANY LTD.
3-6-29 Nishiki Naka-ku Nagoya-shi Aichi 460-8625 Japan
Inventors
1. KITAMURA Takahiro
c/o Fuji Research Laboratories KOWA COMPANY LTD. 332-1 Oonoshinden Fuji-Shi Shizuoka 417-0845 Japan
2. YAMADA Hajime
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
3. TAKEMURA Shunji
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
4. ASHIKAWA Masanori
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
5. ISHIKAWA Tetsuya
c/o KOWA COMPANY LTD. 3-4-14 Nihonbashi hon-cho Chuo-ku Tokyo 103-8433 Japan
6. MIYAKE Yoshiharu
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
7. KOUKETSU Akiyasu
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
8. SATO Seiichi
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
9. ISHIWATA Hiroyuki
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
10. TABUNOKI Yuichiro
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
11. SHIBASAKI Manabu
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
12. OZAWA Takatoshi
c/o KOWA COMPANY LTD. 3-4-14 Nihonbashi hon-cho Chuo-ku Tokyo 103-8433 Japan
13. SHIGEMI Ryota
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
14. DOI Takeshi
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
15. TAMURA Masahiro
c/o Tokyo New Drug Research Laboratories KOWA COMPANY LTD. 2-17-43 Noguchi-cho Higashimurayama-shi Tokyo 189-0022 Japan
Specification
PLEASE SEE THE SPECIFICATION ATTACHED
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 1323-MUMNP-2011-Claims-261214.pdf | 2018-08-10 |
| 1 | 1323-MUMNP-2011-WO INTERNATIONAL PUBLICATION REPORT A9(13-10-2011).pdf | 2011-10-13 |
| 2 | 1323-MUMNP-2011-CORRESPONDENCE(1-7-2011).pdf | 2018-08-10 |
| 2 | 1323-MUMNP-2011-PCT-IB-311(13-10-2011).pdf | 2011-10-13 |
| 3 | 1323-MUMNP-2011-CORRESPONDENCE(13-9-2011).pdf | 2018-08-10 |
| 3 | 1323-MUMNP-2011-CORRESPONDENCE(13-10-2011).pdf | 2011-10-13 |
| 4 | 1323-MUMNP-2011-FORM 3(30-12-2011).pdf | 2011-12-30 |
| 4 | 1323-MUMNP-2011-CORRESPONDENCE(15-1-2014).pdf | 2018-08-10 |
| 5 | 1323-MUMNP-2011-CORRESPONDENCE(30-12-2011).pdf | 2011-12-30 |
| 5 | 1323-MUMNP-2011-CORRESPONDENCE(29-1-2014).pdf | 2018-08-10 |
| 6 | 1323-MUMNP-2011-CORRESPONDENCE(IPO)-(FER)-(29-04-2014).pdf | 2014-04-29 |
| 6 | 1323-MUMNP-2011-CORRESPONDENCE(31-7-2012).pdf | 2018-08-10 |
| 7 | 1323-MUMNP-2011-FORM 3(01-07-2014).pdf | 2014-07-01 |
| 7 | 1323-MUMNP-2011-CORRESPONDENCE(8-5-2015).pdf | 2018-08-10 |
| 8 | 1323-MUMNP-2011-Correspondence-030615.pdf | 2018-08-10 |
| 8 | 1323-MUMNP-2011-CORRESPONDENCE(01-07-2014).pdf | 2014-07-01 |
| 9 | 1323-MUMNP-2011-Correspondence-091216.pdf | 2018-08-10 |
| 9 | 1323-MUMNP-2011-REPLY TO EXAMINATION REPORT(29-10-2014).pdf | 2014-10-29 |
| 10 | 1323-MUMNP-2011-Correspondence-220216.pdf | 2018-08-10 |
| 10 | 1323-MUMNP-2011-OTHER DOCUMENT(29-10-2014).pdf | 2014-10-29 |
| 11 | 1323-MUMNP-2011-ENGLISH TRANSLATION(1-7-2011).pdf | 2018-08-10 |
| 11 | 1323-MUMNP-2011-FORM 3(29-10-2014).pdf | 2014-10-29 |
| 12 | 1323-MUMNP-2011-Examination Report Reply Recieved-261214.pdf | 2018-08-10 |
| 12 | Form 3 [23-05-2016(online)].pdf | 2016-05-23 |
| 13 | 1323-MUMNP-2011-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(20-10-2016).pdf | 2016-10-20 |
| 13 | 1323-MUMNP-2011-FORM 1(31-7-2012).pdf | 2018-08-10 |
| 14 | 1323-MUMNP-2011-FORM 13(31-7-2012).pdf | 2018-08-10 |
| 14 | HEARING ADJOURNMENT [28-10-2016(online)].pdf | 2016-10-28 |
| 15 | 1323-MUMNP-2011-FORM 18(13-9-2011).pdf | 2018-08-10 |
| 15 | HEARING ADJOURNMENT [28-11-2016(online)].pdf | 2016-11-28 |
| 16 | 1323-MUMNP-2011-FORM 3(15-1-2014).pdf | 2018-08-10 |
| 16 | Form 26 [01-12-2016(online)].pdf | 2016-12-01 |
| 17 | Other Patent Document [18-01-2017(online)].pdf | 2017-01-18 |
| 17 | 1323-MUMNP-2011-FORM 3(29-1-2014).pdf | 2018-08-10 |
| 18 | 1323-MUMNP-2011-Form 3-030615.pdf | 2018-08-10 |
| 18 | 1323-MUMNP-2011-Written submissions and relevant documents (MANDATORY) [07-03-2018(online)].pdf | 2018-03-07 |
| 19 | 1323-MUMNP-2011-Form 3-220216.pdf | 2018-08-10 |
| 19 | Petition .pdf | 2018-08-10 |
| 20 | 1323-MUMNP-2011-Form 3-261214.pdf | 2018-08-10 |
| 20 | Form-5.pdf | 2018-08-10 |
| 21 | 1323-MUMNP-2011-HearingNoticeLetter.pdf | 2018-08-10 |
| 21 | Form-3.pdf | 2018-08-10 |
| 22 | 1323-MUMNP-2011-OTHERS-261214.pdf | 2018-08-10 |
| 22 | Form-1.pdf | 2018-08-10 |
| 23 | 1323-MUMNP-2011-Power of Attorney-091216.pdf | 2018-08-10 |
| 23 | ABSTRACT1.JPG | 2018-08-10 |
| 24 | 1323-MUMNP-2011_EXAMREPORT.pdf | 2018-08-10 |
| 25 | ABSTRACT1.JPG | 2018-08-10 |
| 25 | 1323-MUMNP-2011-Power of Attorney-091216.pdf | 2018-08-10 |
| 26 | 1323-MUMNP-2011-OTHERS-261214.pdf | 2018-08-10 |
| 26 | Form-1.pdf | 2018-08-10 |
| 27 | 1323-MUMNP-2011-HearingNoticeLetter.pdf | 2018-08-10 |
| 27 | Form-3.pdf | 2018-08-10 |
| 28 | 1323-MUMNP-2011-Form 3-261214.pdf | 2018-08-10 |
| 28 | Form-5.pdf | 2018-08-10 |
| 29 | 1323-MUMNP-2011-Form 3-220216.pdf | 2018-08-10 |
| 29 | Petition .pdf | 2018-08-10 |
| 30 | 1323-MUMNP-2011-Form 3-030615.pdf | 2018-08-10 |
| 30 | 1323-MUMNP-2011-Written submissions and relevant documents (MANDATORY) [07-03-2018(online)].pdf | 2018-03-07 |
| 31 | 1323-MUMNP-2011-FORM 3(29-1-2014).pdf | 2018-08-10 |
| 31 | Other Patent Document [18-01-2017(online)].pdf | 2017-01-18 |
| 32 | 1323-MUMNP-2011-FORM 3(15-1-2014).pdf | 2018-08-10 |
| 32 | Form 26 [01-12-2016(online)].pdf | 2016-12-01 |
| 33 | 1323-MUMNP-2011-FORM 18(13-9-2011).pdf | 2018-08-10 |
| 33 | HEARING ADJOURNMENT [28-11-2016(online)].pdf | 2016-11-28 |
| 34 | 1323-MUMNP-2011-FORM 13(31-7-2012).pdf | 2018-08-10 |
| 34 | HEARING ADJOURNMENT [28-10-2016(online)].pdf | 2016-10-28 |
| 35 | 1323-MUMNP-2011-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(20-10-2016).pdf | 2016-10-20 |
| 35 | 1323-MUMNP-2011-FORM 1(31-7-2012).pdf | 2018-08-10 |
| 36 | Form 3 [23-05-2016(online)].pdf | 2016-05-23 |
| 36 | 1323-MUMNP-2011-Examination Report Reply Recieved-261214.pdf | 2018-08-10 |
| 37 | 1323-MUMNP-2011-ENGLISH TRANSLATION(1-7-2011).pdf | 2018-08-10 |
| 37 | 1323-MUMNP-2011-FORM 3(29-10-2014).pdf | 2014-10-29 |
| 38 | 1323-MUMNP-2011-Correspondence-220216.pdf | 2018-08-10 |
| 38 | 1323-MUMNP-2011-OTHER DOCUMENT(29-10-2014).pdf | 2014-10-29 |
| 39 | 1323-MUMNP-2011-Correspondence-091216.pdf | 2018-08-10 |
| 39 | 1323-MUMNP-2011-REPLY TO EXAMINATION REPORT(29-10-2014).pdf | 2014-10-29 |
| 40 | 1323-MUMNP-2011-CORRESPONDENCE(01-07-2014).pdf | 2014-07-01 |
| 40 | 1323-MUMNP-2011-Correspondence-030615.pdf | 2018-08-10 |
| 41 | 1323-MUMNP-2011-CORRESPONDENCE(8-5-2015).pdf | 2018-08-10 |
| 41 | 1323-MUMNP-2011-FORM 3(01-07-2014).pdf | 2014-07-01 |
| 42 | 1323-MUMNP-2011-CORRESPONDENCE(IPO)-(FER)-(29-04-2014).pdf | 2014-04-29 |
| 42 | 1323-MUMNP-2011-CORRESPONDENCE(31-7-2012).pdf | 2018-08-10 |
| 43 | 1323-MUMNP-2011-CORRESPONDENCE(30-12-2011).pdf | 2011-12-30 |
| 43 | 1323-MUMNP-2011-CORRESPONDENCE(29-1-2014).pdf | 2018-08-10 |
| 44 | 1323-MUMNP-2011-FORM 3(30-12-2011).pdf | 2011-12-30 |
| 44 | 1323-MUMNP-2011-CORRESPONDENCE(15-1-2014).pdf | 2018-08-10 |
| 45 | 1323-MUMNP-2011-CORRESPONDENCE(13-9-2011).pdf | 2018-08-10 |
| 45 | 1323-MUMNP-2011-CORRESPONDENCE(13-10-2011).pdf | 2011-10-13 |
| 46 | 1323-MUMNP-2011-PCT-IB-311(13-10-2011).pdf | 2011-10-13 |
| 46 | 1323-MUMNP-2011-CORRESPONDENCE(1-7-2011).pdf | 2018-08-10 |
| 47 | 1323-MUMNP-2011-Claims-261214.pdf | 2018-08-10 |
| 47 | 1323-MUMNP-2011-WO INTERNATIONAL PUBLICATION REPORT A9(13-10-2011).pdf | 2011-10-13 |